Drug & intervention

tiotropium

RxCUI 69120

Clinical trials125
Recruiting0
Related conditions12
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

tiotropium

Wikidata Q27088996 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDNCT07541378 · 2024-03-11
SUSPENDED
Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary DiseaseNCT06525051 · 2023-10-23
COMPLETED
Phase 4 COPD and Suboptimal Inspiratory Flow RateNCT05165485 · 2022-01-07
COMPLETED
Exacerbation Risk in AsthmaNCT05501639 · 2021-05-14
COMPLETED
Replication of the POET-COPD Trial in Healthcare Claims DataNCT05083429 · 2020-09-22
COMPLETED
Replication of the INSPIRE Trial in Healthcare Claims DataNCT05179512 · 2020-09-22
COMPLETED
Early Intervention Efficacy in COPDNCT04249310 · 2020-03-27
COMPLETED
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled AsthmaNCT03376932 · 2019-01-18
WITHDRAWN
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03478683 · 2018-06-25
COMPLETED
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03478696 · 2018-06-25
COMPLETED
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03474081 · 2018-03-29
COMPLETED
Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPDNCT03258749 · 2017-11-01
UNKNOWN
The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusNCT03240575 · 2017-08-14
COMPLETED
Cardiovascular Function in COPD PatientsNCT03055988 · 2017-03-29
COMPLETED
Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsNCT02969317 · 2017-02-24
COMPLETED
Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsNCT02853123 · 2016-09-22
COMPLETED
Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination TreatmentNCT02988869 · 2016-08-01
COMPLETED
Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPDNCT02683109 · 2016-03-08
COMPLETED
Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)NCT02872090 · 2016-03-01
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsNCT02629965 · 2016-02-12
COMPLETED
Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPDNCT02603393 · 2015-11-20
COMPLETED
Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine ChallengeNCT02622243 · 2015-11-01
COMPLETED
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)NCT02518139 · 2015-09-01
COMPLETED
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate AsthmaticsNCT02382510 · 2015-04-01
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13
COMPLETED
A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsNCT02275481 · 2014-11-01
TERMINATED
Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus TiotropiumNCT02257385 · 2014-10-15
COMPLETED
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary DiseaseNCT02207829 · 2014-09-01
COMPLETED
Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD PatientsNCT02125734 · 2014-04-01
COMPLETED
To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of AirwaysNCT02085161 · 2014-03-01
COMPLETED
Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPDNCT01959516 · 2014-02-01
COMPLETED
Evaluation of Long-Acting Muscarinic Antagonists in COPDNCT02039050 · 2014-02-01
COMPLETED
Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different InhalersNCT02030535 · 2014-01-01
COMPLETED
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary DiseaseNCT01911364 · 2014-01-01
COMPLETED
Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)NCT01964352 · 2013-11-01
COMPLETED
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)NCT02006732 · 2013-11-01
COMPLETED
Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsNCT01969721 · 2013-10-01
COMPLETED
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01922271 · 2013-08-01
COMPLETED
Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD)NCT02473237 · 2013-04-01
COMPLETED
Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD PatientsNCT01727024 · 2013-04-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.